- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04503343
Effects of Non-drug Therapy on Cognitive Function in Healthy Individuals and Patients With First Episode Depression
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this proposed study,the investigators will evaluate the effects of different non-pharmacological interventions (physical/psychological) on emotion-related cognitive function.This project will use a variety of intervention methods to conduct research in healthy individuals and patients with mood disorders. The main intervention methods include: (1) mindfulness training;(2) relaxation training;(3) cerebellar electrical stimulation.
The study will recruit 80 healthy subjects and 40 first-episode depression patients. The study consisted of three steps: First, subjects filled in personal data and completed the first screening, randomly assigned groups, and filled in the pre-intervention questionnaire;Second, give a one-time non-drug intervention (mindfulness training, relaxation training or cerebellar electrical stimulation);Step 3: After the intervention, the subjects filled in the post-intervention questionnaire and completed the cognitive task test.Clinical efficacy and safety assessment will be done at first time. The specific aims are to evaluate the effect of non-drug therapy on cognitive function in healthy individuals and patients with first episode depression. and the behavior was evaluated by cognitive function task.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410011
- The Second Xiangya Hospital Of Central South University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-
Healthy individuals group:
- Aged between 16 and 34;
- Does not meet the criteria of the DIAGNOSTIC and Statistical Manual of Mental Disorders, DSM-5,Does not meet the diagnosis of depression, bipolar disorder and other mental disorders.
First episode depression group:
- Aged between 16 and 34;
- Clinically diagnosed as having depression according to the DIAGNOSTIC and Statistical Manual of Mental Disorders (DSM-5);
- First attack, not taking medicine, no risk of serious suicide NSSI.
Exclusion Criteria:
- There are serious physical diseases, such as epilepsy, brain trauma, intracranial space-occupying lesions, severe audiovisual disorders, congenital heart disease, etc.;
- Both Hamilton Depression Scale and Beck Depression Self-Rating Scale indicate severe depression or severe mental illness;
- Affected by mental illness, it is difficult to conduct smooth and effective verbal communication and psychological measurement operation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: intervention group
subjects are randomly divided into the intervention group.
and they will be given a one-time non-drug intervention(mindfulness training, relaxation training or electrical cerebellar stimulation).
|
mindfulness training, relaxation training, or electrical cerebellar stimulation
|
No Intervention: control group
subjects are randomly divided into the control group and regularly followed up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of mindfulness training on cognitive function in healthy individuals
Time Frame: baseline
|
Cognitive function are measured by Faces Emotion Recognition Task
|
baseline
|
The change of mindfulness training on cognitive function in patients with first episode depression
Time Frame: baseline
|
Cognitive function are measured by Emotional Categorisation Task
|
baseline
|
The change of cerebellar electrical stimulation on cognitive function in healthy individuals
Time Frame: baseline
|
Cognitive function are measured by Emotional Recall Task
|
baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MD201908
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Disorder
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDepressive Disorder, Major Depressive DisorderUnited States
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
Clinical Trials on non-drug intervention
-
Institut Claudius RegaudCompletedMetastatic Breast Cancer Starting a Third Line ChemotherapyFrance
-
University Hospital, ToulouseActive, not recruitingMidgut Neuroendocrine TumorsFrance
-
Tianjin Happy Life Technology Co., Ltd.Unknown
-
GlaxoSmithKlineCompletedCancerKorea, Republic of, Hong Kong, Pakistan, Singapore
-
Swiss Federal Institute of TechnologySwiss Tropical & Public Health Institute; Ifakara Health InstituteCompleted
-
LEO PharmaCompleted
-
University Hospital BirminghamBoston Scientific CorporationUnknownStenosis | Native Arteriovenous FistulaUnited Kingdom
-
Ehsan M saiedUnknownConvulsive Seizures
-
Taichung Veterans General HospitalHungkuang UniversityCompletedVertebral Compression Fracture | Posture
-
China Resources Biopharmaceutical Co., LtdPeking University Third HospitalRecruiting